Member Info for BoNidel

Yet another spread bet of mine closed.

No shares tradeable

No responses to any of my numerous emails sent to the IR Over the last few months.

No Accustem

No trials as announced

No precision update

No reason for the massive continuous cash burn.

We’ve all been had ??

Sub 30p now. Where’s that plumber gone?

Fantastic

Sad to hear of the passing of Dr Adams. A big name at Cardiff university and in the biotech area.

Let’s all keep posts respectful today following this press release earlier.

Posted august 2021,

“ Stakebuilding talk in Tiziana Life Sciences

There is talk of stakebuilding in Tiziana Life Sciences, a developer of treatments for infectious diseases.

The company's shares have come under pressure recently after it said it was looking at leaving the London main market and relisting in the US on the Nasdaq.

The word is an American hedge fund that specialises in biotechnology stocks has seen the low share price as an opportunity to build a sizeable stake in the business and may soon disclose it publicly.”

Source: This is money

What happened to this? Who is buying the damn shares? Is it being shorted to death? If so is It for a cheap takeover with a phantom premium or just to profit from the shorting?

If GC is that confident why doesn’t he just keep buying? Maybe he is?

God knows. Would love to see this turn though, it’s been nothing but punishment for the last year really.

Say that again to yourself, 12 whole weeks with UK shares not tradeable. This is bullsh*t.

65 odd weeks with no Accustem either???

UK Shares not tradable yet, no sign of Accustem & share price down from 58.8p to UK equivalent 32.5p?

Where is the plumber when you need him? Didn’t he say last March something about a dual Accustem listing off the bat?

If Accustem was delivered successfully, surely it would give a much needed boost to the long suffering holders here. Why the hell hasn’t it listed!!!

Maybe it’s just that biotech is so bad at the moment he would rather the flack and keep it shelved until things turn a corner.

Maybe it’s undergoing takeover & it’s being triple checked prior to this happening? Just seems crazy for it not to list judging from what I’ve read…

Every week I think “surely it can’t be that much longer”
…

Wish we knew what a “favourable” clinical response meant..

Always wondered why GC didn’t buy more shares if he was they confident. I guess he only values it as a good investment at these low prices

How long can this go on for? Why the hell would anyone sell at this price!

Will UK holders also dump when they are able to trade (finally?) what are we now 80-85% down?

Utter madness.

Look at the volume today as well, it looks like it will breach 400k volume by end of play so 3x normal 3m average volume. Who the hell is selling & if they are then someone is definitely buying!

Although Im sick and tired of TILS and the BOD I would find it delightful if they did announce something huge and suspend trading.

The performance of this has been disgusting but has been amplified by the BOD missing deadlines and the whole Accustem debacle. Then to see Mr GC gobble up shares at these prices it really is gangster-like.

I think most of us are now up the wrong way on this but WHO IS SELLING. There’s nothing much left to lose ffs!

I will hold this until the bitter f*cking end I can guarantee that.

Weak people have caused this, but in their defence I understand (to a degree). I have spent the last 12 months saying “well surely it can’t go much lower!”

Sadly it’s irrelevant currently as only 19 shares have traded hands…

Pretty significant news actually. Any favourable outcomes (however small) will be big if there are no side effects.

Let’s see how the market reacts to this.

Previously told me that they are settled with HSBC now (the custodian) but that they need to clear through crest or something.

The whole thing is just a joke.

No sign of Accustem or Tils shares in the HL account.

Many of the serial rampers have disappeared.

Fairy obvious now on stocktwits/ADVFN that there a paid de-rampers but to be fair there is not a lot left to defend here now.

To top it off GC seems to have taken advantage of the 52w low that has been driven by The Accustem debacle & this c**k up so on the plus side he owns more of the company now. What’s more, there will probably be no news due over the next few weeks now because of the director buy.

Hopefully I’m wrong.

Well and truly “had” as it were

TILS shares in HL still not showing as consolidated TLSA shares. Seems like nothing has happened since the switch.

Looks like the markets didn’t find the increased stake as exciting as some of us on here.

I suppose it probably means no news due for a while longer!… doesn’t seem to disclose as much as a UK PDMR RNS.

Unless it’s possible to buy directly off the other major holders? The “percentage of securities not in public hands” is now closed to 46% if these were open market trades…

So based on average 3 monthly volume, GC has been almost the sole buyer for the past 57 days?…

Stinks a bit as it’s been handled so poorly. But to be fair, $6m-$10m Buy is really putting your money where your mouth is. That is an enormous director deal for a small cap public listed company

I wonder what the average price was.

Crazy thing is it must have been mostly sellers aside from GC the past 2 months! What would the SP be without those buys?

Unless it is somehow something to do with the previous shelf offering (although I highly doubt that).

Unless we are misinterpreting, this is massive news.

He works for Stifel.

Bit of a strange one but it was clear that GC is frustrated but then they moved from aim to main market and then have jumped to Nasdaq?

There seemed to be a bit of ever so slightly schoolyard one-upmanship from the renaltyx CEO with regards to how he always is transparent with how they keep shareholders up to date.

The chap from Stifel makes the point then that he never makes renalytix provide any pointless updates (was the insinuating that GC isn’t using the correct nomads and should be using Stifel?)

I remember around year or so ago GC having an interview where he talks about the FractalDX demerger from renalytix and how the value of the 2 companies split was 3 times what it was as one.

I am wondering if GC has got these guys (dechert/etc) on board to try and really stimulate the SP in the US as they are going to need to raise again at some stage.

I’m majorly ****ed off at the SP and the contact from the BOD now but can see that there’s a bit of a plan. I’m not saying they are withholding news now but it would probably be more suitable for news to happen then they are solely NAS Listed so the sp can fly on good news and hopefully stay up there as well.

Any majorly good news may have been wasted on the dual listing. As we witnessed, the UK listing mainly just followed the US but slightly behind. Arbitrage has ruined the SP as much as anything..

I think the Accustem demerger has been changed following GC taking advice and now a sole nas listing is the best place for it so it doesn’t get held back. I would assume they are waiting for the TLSA Listing to finalise to allow the SP to move on positive Accustem news (even thought the two are technically unrelated now) and then to provide further trials, partnerships & updates to jump off the already increased price.

I suppose they can’t really update us and say that they have no clue what’s happened to the SP but hope a sole nas listing will bring it back.

Looking at the figures, nasdaq is the way to due to much higher and more readily available access to capital and I hope we can put these last rubbish 12 months behind us.

There were some further interesting points in that a lot of these guys are big into m&a and a host of other things which aren’t springing to mind right now (will post later if the do) but it sure was a weird 2020 with TIziana & I hope the long standing shareholders get rewarded for their loyalty soon enough!…